BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 33599568)

  • 21. COVID-19 Vaccination Attitudes and Intention: Message Framing and the Moderating Role of Perceived Vaccine Benefits.
    Borah P; Hwang J; Hsu YCL
    J Health Commun; 2021 Aug; 26(8):523-533. PubMed ID: 34424140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.
    Di Gennaro F; Murri R; Segala FV; Cerruti L; Abdulle A; Saracino A; Bavaro DF; Fantoni M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33652829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Vaccination and the Challenge of Infodemic and Disinformation.
    Farooq F; Rathore FA
    J Korean Med Sci; 2021 Mar; 36(10):e78. PubMed ID: 33724740
    [No Abstract]   [Full Text] [Related]  

  • 24. Covid-19 vaccine hesitancy among ethnic minority groups.
    Razai MS; Osama T; McKechnie DGJ; Majeed A
    BMJ; 2021 Feb; 372():n513. PubMed ID: 33637577
    [No Abstract]   [Full Text] [Related]  

  • 25. Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
    Rosenbaum L
    N Engl J Med; 2021 Apr; 384(14):1367-1371. PubMed ID: 33577150
    [No Abstract]   [Full Text] [Related]  

  • 26. Restoring confidence in vaccines in the COVID-19 era.
    Verger P; Dubé E
    Expert Rev Vaccines; 2020 Nov; 19(11):991-993. PubMed ID: 32940574
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    Muhajarine N; Adeyinka DA; McCutcheon J; Green KL; Fahlman M; Kallio N
    PLoS One; 2021; 16(11):e0259513. PubMed ID: 34767603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.
    Reid JA; Mabhala MA
    Isr J Health Policy Res; 2021 May; 10(1):33. PubMed ID: 34044891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand.
    Thaker J
    J Health Commun; 2021 Feb; 26(2):104-111. PubMed ID: 33719898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
    COCONEL Group
    Lancet Infect Dis; 2020 Jul; 20(7):769-770. PubMed ID: 32445713
    [No Abstract]   [Full Text] [Related]  

  • 31. Protecting individuals living with overweight and obesity: Attitudes and concerns toward COVID-19 vaccination in Canada.
    Vallis M; Glazer S
    Obesity (Silver Spring); 2021 Jul; 29(7):1128-1137. PubMed ID: 33774916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I am struggling to understand why patients decide not to get the covid vaccine.
    Anonymous
    BMJ; 2021 Dec; 375():n3152. PubMed ID: 34952846
    [No Abstract]   [Full Text] [Related]  

  • 33. Stressing the personal benefits of the covid-19 vaccine might encourage more people to accept it.
    Saul H; Gursul D
    BMJ; 2021 Dec; 375():n2923. PubMed ID: 34893477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing Mistrust About COVID-19 Vaccines Among Patients of Color.
    Opel DJ; Lo B; Peek ME
    Ann Intern Med; 2021 May; 174(5):698-700. PubMed ID: 33556271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence.
    Chou WS; Budenz A
    Health Commun; 2020 Dec; 35(14):1718-1722. PubMed ID: 33124475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing minds: A behavioural approach to vaccine hesitancy.
    Joska JA; Rabie S; Sibeko G
    S Afr Med J; 2022 Feb; 112(2):13495. PubMed ID: 35139984
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing Behavioral Economic-Based Approaches to Address COVID-19 Vaccine Hesitancy.
    Ranpariya VK; Hrin ML; Maghen P; Feldman SR
    J Ambul Care Manage; 2021 Oct-Dec 01; 44(4):336-341. PubMed ID: 34319925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response.
    Bhopal S; Nielsen M
    Arch Dis Child; 2021 Feb; 106(2):113-114. PubMed ID: 32912868
    [No Abstract]   [Full Text] [Related]  

  • 39. Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    Argote Tironi P; Barham E; Zuckerman Daly S; Gerez JE; Marshall J; Pocasangre O
    PLoS One; 2021; 16(10):e0259059. PubMed ID: 34710168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Vaccine Communication in a Pandemic: Improving Vaccine Literacy to Reduce Hesitancy, Restore Trust and Immunize Communities": Editor's Introduction.
    Ratzan SC
    J Health Commun; 2020 Oct; 25(10):745-746. PubMed ID: 33719883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.